Sofinnova HealthQuest Partners L.P. 13D and 13G filings for Castle Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-10-08 8:57 pm Sale |
2020-10-05 | 13D | Castle Biosciences, Inc. CSTL |
Sofinnova HealthQuest Partners L.P. | 983,577 4.997% |
-200,000 (-16.90%) |
Filing |
| 2020-07-13 6:45 pm Sale |
2020-07-09 | 13D | Castle Biosciences, Inc. CSTL |
Sofinnova HealthQuest Partners L.P. | 1,183,577 6.000% |
-50,000 (-4.05%) |
Filing |
| 2020-06-24 06:04 am Sale |
2020-06-22 | 13D | Castle Biosciences, Inc. CSTL |
Sofinnova HealthQuest Partners L.P. | 1,233,577 7.200% |
-200,000 (-13.95%) |
Filing |
| 2020-05-14 06:06 am Sale |
2020-05-12 | 13D | Castle Biosciences, Inc. CSTL |
Sofinnova HealthQuest Partners L.P. | 1,433,577 8.300% |
-400,000 (-21.82%) |
Filing |